Cannabis Testing Services Market Size, Share, Growth, and Industry Analysis, By Type (Liquid Chromatography,Gas Chromatography,Others), By Application (Cannabis Drug Manufacturers,Cannabis Cultivators/Growers,Research Institutes,Others), Regional Insights and Forecast to 2035

Cannabis Testing Services Market Overview

The global Cannabis Testing Services Market is forecast to expand from USD 2270.54 million in 2026 to USD 2438.56 million in 2027, and is expected to reach USD 4316.86 million by 2035, growing at a CAGR of 7.4% over the forecast period.

The global Cannabis Testing Services Market was estimated at approximately USD 2,078.2 million in 2024 and is projected to reach around USD 5,389.9 million by 2030. The market is characterized by the dominance of the North American region, accounting for over 60.7 % share of the global market in 2023, while the potency testing service segment represented about 22.8 % of the service mix in 2023. 

The U.S. market for cannabis testing services was valued at about USD 391.1 million in 2024, driven by the requirement for laboratory testing services in states with legal cannabis markets. In the U.S., the spectroscopy technology segment reached roughly USD 1,200 million by 2030, while residual solvent screening was estimated to capture about 14 % of the U.S. testing market by 2030.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: ~60 % of global cannabis testing services demand stems from cultivationlinked testing requirements.
• Major Market Restraint: ~15 % of potential markets remain unserved due to high setup cost and lack of standardized testing protocols.
• Emerging Trends: ~25 % growth in new laboratory establishment globally linked to legalization in AsiaPacific and Latin America. Regional Leadership: ~60.7 % global share retained by North America in 2023.
• Competitive Landscape: ~30 % of service market share concentrated among top five global testing laboratories.
• Market Segmentation: ~22.8 % of the service segment from potency testing in 2023.
• Recent Development: ~45 % increase in adoption of spectroscopy vs chromatography in U.S. labs by 2030.

Cannabis Testing Services Market Latest Trends

The Cannabis Testing Services Market Latest Trends reveal that the potency testing segment is gaining traction globally, having accounted for about USD 373.3 million in 2023 of total service revenue. Meanwhile, the residual solvent screening segment is forecast to represent approximately 14 % of the U.S. market by 2030, and the spectroscopy technology category is projected to achieve around USD 1,200 million in U.S. revenue by 2030. Some 45 % share of the analytical instrument segment globally is expected in 2025. 

Testing laboratories are increasingly incorporating high‐throughput instrumentation (GCMS, LCMS, ICPMS), and about 63 % of the global testing services market revenue in 2023 was attributed to catering to cultivators/growers. Regulatory drivers are strong: more than 38 U.S. states permit medical cannabis and 24 states plus territories allow recreational use.

Cannabis Testing Services Market Dynamics

DRIVER

"Rising demand for standardized testing due to legalization and quality control"

The main driver of market growth in the Cannabis Testing Services Market is the escalating demand for standardized testing services as jurisdictions legalize cannabis for medical and recreational use.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Potency testing:   the primary diagnostic service used to quantify cannabinoids such as THC and CBD in raw flower and finished products. Potency assays use validated methods—HPLC, UHPLC and GC workflows—and account for a large share of laboratory throughput: potency accounted for about 22.8% of all standard test panels in 2023.

Potency testing Market Size, Share and CAGR: The potency testing segment represented approximately 22.8% of a global market base estimated at ~USD 1.6–1.8 billion in 2023, with implied segment revenues near USD 360–410 million and midteens CAGR projections reported by multiple analysts. 

Top 5 Major Dominant Countries in the Potency Testing Segment

• United States — Potency segment market size ~USD 220–250 million, share ~55–61% of global potency testing, CAGR in reports ~15–18% (reflecting mature regulated states and high persample frequency). 
• Canada — Potency segment market size ~USD 35–45 million, share ~9–11%, CAGR ~12–16% as federally regulated adultuse testing volumes remain stable. 
• Germany — Potency segment market size ~USD 18–25 million, share ~4–6%, CAGR ~13–15% driven by medical cannabis programs and imports. 
• Australia — Potency segment market size ~USD 12–18 million, share ~3–5%, CAGR ~12–14% as medical program and industrial hemp testing expand. 
• Netherlands — Potency segment market size ~USD 9–14 million, share ~2–3.5%, CAGR ~10–13% reflecting EU export and GMP testing demand. 

Pesticide screening:  the single most frequently mandated test category by regulators across jurisdictions and often represents the largest persample test bundle. Pesticide panels vary in breadth—some states require 60+ analytes—so pesticide screening accounted for roughly 28% of test volumes in 2023, and in highregulation jurisdictions pesticide panels represent up to 40% of a lab’s test complexity per sample. 

Pesticide screening Market Size, Share and CAGR: The pesticide screening type represented about 28% of the global market base (~USD 1.6–1.8 billion), implying segment values near USD 450–500 million, with CAGR estimates commonly reported in the low to midteens. 

Top 5 Major Dominant Countries in the Pesticide Screening Segment

• United States — Pesticide segment market size ~USD 260–290 million, share ~57–62% of global pesticide testing, CAGR ~15–18% due to strict state lists and retesting rates. 
• Canada — Pesticide segment market size ~USD 40–48 million, share ~8–11%, CAGR ~11–15% as licensed producers meet federal pesticide standards. 
• Germany — Pesticide segment market size ~USD 20–26 million, share ~4–6%, CAGR ~12–14% given import controls and medicinal product testing. 
• Australia — Pesticide segment market size ~USD 10–16 million, share ~2–4%, CAGR ~11–13% from expanding medical hemp cultivation. 
• Colombia — Pesticide segment market size ~USD 8–12 million, share ~1.5–3%, CAGR ~13–16% as large outdoor cultivation needs residue monitoring.

Heavy metals screening : lead, cadmium, arsenic, mercury) is a compact but critical panel required by most regulators and buyers. Heavy metal assays accounted for about 12% of testing volumes in 2023, typically performed by ICPMS or AAS platforms with limits of detection in the low ppb range; labs report persample heavy metal testing adds 1–2 additional instrument runs and usually carries higher pertest margins. 

Heavy metals Market Size, Share and CAGR: Heavy metals testing captured ~12% of an estimated ~USD 1.6–1.8 billion market, suggesting segment values near USD 190–220 million, with CAGR estimates often in the low to midteens. 

Top 5 Major Dominant Countries in the Heavy Metals Segment

• United States — Heavy metals segment market size ~USD 100–120 million, share ~50–55% of global heavy metals testing, CAGR ~12–15% supported by soil testing and finished product checks. 
• Canada — Heavy metals segment market size ~USD 18–24 million, share ~8–10%, CAGR ~11–13% due to federal food safety alignment. 
• Germany — Heavy metals segment market size ~USD 9–14 million, share ~4–6%, CAGR ~10–12% from pharmaceuticalgrade imports. 
• Australia — Heavy metals segment market size ~USD 6–10 million, share ~2–4%, CAGR ~10–12% linked to hemp testing. 
• Colombia — Heavy metals segment market size ~USD 4–8 million, share ~1–3%, CAGR ~11–14% as outdoor cultivation scales. 

Residual solvent:  testing examines extraction solvents in concentrates and extracts and is essential for vape and concentrate producers. Residual solvent analysis made up about 10% of test volumes in 2023, typically performed by headspace GCMS with detection limits tied to ppm thresholds; extraction processors usually submit 2–5 residual solvent samples per batch, and retest rates on solvent exceedance average 3–6% in regulated markets. 

Residual solvents Market Size, Share and CAGR: Residual solvent testing represented ~10% of the ~USD 1.6–1.8 billion base, implying segment sizing near USD 160–180 million, with CAGR commonly estimated in the lowteens. 

Top 5 Major Dominant Countries in the Residual Solvents Segment

• United States — Residual solvents market size ~USD 85–100 million, share ~50–55% of global residual solvent testing, CAGR ~12–15% due to concentrate production. 
• Canada — Residual solvents market size ~USD 12–18 million, share ~6–10%, CAGR ~11–14% from licensed extractors. 
• Germany — Residual solvents market size ~USD 8–12 million, share ~3–5%, CAGR ~10–12% for pharmaceutical imports. 
• Australia — Residual solvents market size ~USD 6–9 million, share ~2–4%, CAGR ~10–12% as concentrates grow. 
• Uruguay — Residual solvents market size ~USD 3–6 million, share ~1–2%, CAGR ~11–13% tied to export testing and smallscale extraction.

BY APPLICATION 

Liquid Chromatography (LC/ HPLC/ UHPLC) :  the backbone application for potency and many pesticide/contaminant workflows in cannabis testing laboratories. LC platforms accounted for the largest share by technology in 2023–2024 due to potency profiling (cannabinoids) and many pesticide residues that are polar and nonvolatile; analyst reports attribute roughly 40–55% of instrument usage hours in typical cannabis labs to LC systems. 

Liquid Chromatography Market Size, Share and CAGR: LC application covered ~45–50% of the technology spend on cannabis testing instrumentation, representing a sizable portion of the global testing market with CAGR estimates in the midteens. 

Top 5 Major Dominant Countries in the Liquid Chromatography Application

• United States — LC application market size ~USD 650–750 million equivalent demand, share ~50–55% of global LC usage, CAGR ~14–17% as potency remains primary. :
• Canada — LC application market size ~USD 95–125 million equivalent, share ~8–10%, CAGR ~12–15% in federal labs. 
• Germany — LC application market size ~USD 70–95 million equivalent, share ~4–6%, CAGR ~11–14% in medical supply chains. 
• Australia — LC application market size ~USD 45–70 million equivalent, share ~2–4%, CAGR ~11–13% with medical testing growth. 
• Netherlands — LC application market size ~USD 30–50 million equivalent, share ~1–3%, CAGR ~10–13% due to export certification. 

Gas Chromatography (GC/ GCMS/ GCFID) :  widely used for residual solvents, terpene profiling and volatile pesticide residues in cannabis testing workflows. GC instruments accounted for approximately 30–35% of instrument usage hours in many labs in 2023, given residual solvent panels and terpene profiles rely on GCbased separations; GC cycle times for terpene profiling are often 10–30 minutes per run, and headspace autosamplers are a common accessory. 

Gas Chromatography Market Size, Share and CAGR: GC application accounted for ~30–35% of technology spend and instrument utilization, with segment CAGR often estimated in the low to midteens. 

Top 5 Major Dominant Countries in the Gas Chromatography Application

• United States — GC application market size ~USD 450–520 million equivalent demand, share ~50–55% of global GC usage, CAGR ~13–16% linked to concentrate production. 
• Canada — GC application market size ~USD 60–85 million equivalent, share ~8–10%, CAGR ~12–14% from licensed extractors. 
• Germany — GC application market size ~USD 40–60 million equivalent, share ~4–6%, CAGR ~11–13% for terpene and residual solvent testing.
• Netherlands — GC application market size ~USD 30–50 million equivalent, share ~2–4%, CAGR ~10–12% for extractors and exporters. 
• Australia — GC application market size ~USD 25–40 million equivalent, share ~1–3%, CAGR ~10–12% as concentrates expand. 

Cannabis Testing Services Market Regional Outlook 

The Cannabis Testing Services Market shows marked regional divergence: North America held approximately 60.7% of global market share in 2023, Europe contributed roughly 20%–25%, AsiaPacific represented near 10%–15% but is the fastestgrowing region, and Middle East & Africa accounted for under 5%–8% of addressable demand. Market infrastructure counts include hundreds of licensed testing labs in North America .

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America 

North America is the dominant region in the Cannabis Testing Services Market, accounting for about 60.7% of global share in 2023 and hosting the largest concentration of regulated testing infrastructure with over 600 laboratories across the U.S. and Canada by 2024. The United States alone recorded a testing market valuation of roughly USD 391.1 million in 2024 with more than 38 states permitting medical cannabis and over 24 jurisdictions allowing adultuse as of early 2024, driving mandatory test panels for potency, pesticides, heavy metals, microbial contaminants and residual solvents. 

North America Market Size, Share, and CAGR. The North America cannabis testing services market represented about 60.7% share in 2023, with regional market size estimates varying by source and CAGR projections commonly reported between 12%–17% across 2024–2030.

North America Major Dominant Countries in the “Cannabis Testing Services Market”

• United States — Market size for testing services estimated at ~USD 391.1 million in 2024, representing roughly 55%–62% of North American testing activity with CAGR projections commonly reported at 10%–15%. 
• Canada — Testing services market share approximated at 20%–25% of North America in 2024, with more than 100 licensed producers submitting mandatory COAs and national test lists of 50–60 pesticides. 
• Mexico — Formal commercial testing footprint relatively small but expanding; market share under 5%–7% in 2024 with pilot programs and export compliance activity rising by ~20% yearoveryear. 
• Puerto Rico — Emerging testing hub with regulated cannabis programs since 2017, representing ~1%–2% of North American testing volumes and showing multilab accreditation growth near 10%–15%. 
• Jamaica — Small but fastgrowing medicinal hemp and testing activity, market share under 1%–2% for North America with expected increases in licensed lab counts by ~5%–10%. 

Europe 

Europe holds a meaningful portion of global cannabis testing demand—estimates cluster around 20%–25% of global market share in recent market tallies—driven primarily by medical cannabis programs, GMP import/export controls and rising domestic cultivation in countries such as Germany, the Netherlands and Denmark. As of 2024, Europe reported more than 200 accredited cannabis and hemp testing laboratories, with German clinical programs and Dutch export testing accounting for large shares of analytic complexity .

Europe Market Size, Share, and CAGR. Europe accounted for approximately 20%–25% of the global testing market in 2023, with market size estimates varying and CAGR projections typically ranging from 10%–14% across 2024–2030. 

Europe Major Dominant Countries in the “Cannabis Testing Services Market”

• Germany — Market share estimated at roughly 18%–22% of Europe’s testing volumes, with clinical and import testing driving increased heavymetal and pesticide panels and CAGR estimates often shown at 11%–14%. 
• Netherlands — Share near 12%–16% of European testing activity in 2024 due to export certification and processing hubs, with specialized terpene and residual solvent workloads representing ~30%–40% of local lab throughput. 
• United Kingdom — Despite regulatory complexity, UK labs provided ~8%–12% of EU/Europe testing capacity in 2024, with advanced cannabinoid profiling and research testing counts growing by ~15% annually. 
• Denmark — Share roughly 4%–7% driven by pharmaceutical production and clinical trial testing, with specialized GMP analytics and export compliance panels increasing by ~10%–12%. 
• Switzerland — NonEU but large testing contributor with ~3%–6% of European capacity focused on R&D, stability and highprecision potency assays, growing lab counts near 8%–10%. 

AsiaPacific 

AsiaPacific is an emergent and accelerating region for cannabis testing services: while representing only about 10%–15% of current global market share in 2023–2024, APAC posted the fastest relative growth rates with lab counts and service demand rising by approximately 20%–40% yearoveryear in 2023–2024 as countries revise medical/hemp rules. Major markets within APAC such as Australia and Israel (Middle East technically but APACadjacent in testing networks).

Asia Market Size, Share, and CAGR. AsiaPacific held an estimated 10%–15% of global testing market share in 2024, with CAGR projections typically higher than mature regions—commonly reported at 15%–20%+ in market forecasts for 2024–2030. 

Asia Major Dominant Countries in the “Cannabis Testing Services Market”

• Australia — Market share near 25%–30% of APAC testing volumes with growing lab accreditation counts and routine potency/pesticide panels; CAGR estimates often at 11%–14%. 
• Thailand — Rapidly expanding market share estimated at 15%–20% of APAC growth activity due to national medical cannabis programs and product licensing surges; lab counts up by ~30%+. 
• Israel — R&D and clinical testing hub representing ~10%–15% of APAC/Middle East testing capacity with highprecision assays and steady growth near 10%–12%. 
• South Korea — Emerging medical and research testing share ~5%–8%, primarily R&D and clinical trial analytics, with lab investments rising by ~8%–12%. 
• China (Hemp/Research) — Small commercial share but growing hemptesting activity ~3%–6% of APAC testing volumes and notable investment in heavymetal and pesticide screening facilities. 

Middle East & Africa 

Middle East & Africa (MEA) remains the smallest regional block in the cannabis testing landscape, representing under 5%–8% of global testing demand as of 2023–2024, yet it is showing nascent activity and pockets of rapid regulatory change particularly in Africa (South Africa, Lesotho, Zimbabwe) and select Middle Eastern research programs. South Africa and Lesotho have become important outdoor cultivation hubs—Lesotho reported more than 30 licensed cultivation and growing export interest.

Middle East and Africa Market Size, Share, and CAGR. MEA accounted for roughly 5%–8% of global cannabis testing market share in 2023–2024, with forecasted CAGR estimates often cited in the midteens for early adopter countries as regulations evolve. 

Middle East and Africa Major Dominant Countries in the “Cannabis Testing Services Market”

• South Africa — Regional leader with ~30%–40% of MEA testing volumes in 2024, driven by domestic cultivation and export audits, and showing doubledigit increases in accredited test counts. 
• Lesotho — Exportoriented testing activity representing ~15%–25% of MEA cultivation test volumes due to licensed outdoor grows and international compliance needs.
• Zimbabwe — Emerging market share ~8%–12% as commercial cultivation expands and testing infrastructure develops with donor and private investment. 
• Morocco — Small but notable hemp/hempderivative testing share ~5%–8% as agricultural producers seek export certification and residue screening. 
• Israel — Although often grouped separately, Israel contributes ~10%–15% of regional advanced testing capacity focused on R&D and clinical analytics. 

List of Top Cannabis Testing Services Market Companies

• Saskatchewan Research Council (SRC)
• SC Labs
• Steep Hill Inc.
• SGS Canada Inc.
• CW ANALYTICAL
• PharmLabs
• GreenLeaf Lab
• ProVerde Laboratories
• EVIO Labs
• CannaSafe
• Anresco Laboratories
• Digipath Labs
• CDx Analytics

Top two companies with highest share

SC Labs : Operates a multistate network with at least 5 visible U.S. lab locations and was voted “Cannabis Testing Lab of the Year” for two consecutive years (2023–2024), handling tens of thousands of samples annually and claiming the largest national laboratory footprint among independent cannabis testing firms. 

EVIO Labs :  Expanded from one laboratory to 11 labs across 5 U.S. states and Canada and reported performing over 50,000 tests in recent twoyear windows, positioning it among the highestshare independent service providers by sample volume and geographic reach. 

Investment Analysis and Opportunities

Institutional and strategic investors are allocating capital to testing networks and adjacent services because independent labs now handle concentrated sample volumes—some multistate operators report running tens of thousands of tests across doubledigit lab footprints. Large regional players and accredited labs (ISO/IEC 17025 holders) are winning recurring contracts from cultivators and manufacturers; for example, single operators have grown to doubledigit lab counts and performed 10,000–50,000+ tests in trailing twoyear periods.

Market infrastructure needs—LIMS deployment, proficiency testing, and instrument upgrades—create frequent capital projects: an HPLC/GCMS suite plus method validation commonly requires sixfigure equipment and validation schedules measured in weeks to months. 

New Product Development

Innovation in cannabis testing focuses on faster, cheaper and onsite analytics plus digital tools for traceability: portable NIR/Raman and handheld spectroscopy devices now deliver cannabinoid and terpene readouts in seconds to minutes, enabling growers to perform infield screening of THC/CBD and moisture with pertest times under 60 seconds to 10 minutes depending on the platform.  New assay development includes expanded multiresidue pesticide panels (50–100 analytes) and LCMS/MS methods for lowppb heavymetal and mycotoxin detection with validated run times of 6–18 minutes per injection for potency and 3–8 minutes for ICPMS metal scans. Some vendors also offer subscriptionstyle.

Five Recent Developments 

• EVIO Labs national expansion and throughput milestone: EVIO reported expansion from one lab to 11 labs across 5 states and Canada and disclosed performing over 50,000 tests during a recent twoyear period—evidence of scale and samplevolume leadership. 
• SC Labs industry recognition and footprint growth: SC Labs secured “Testing Lab of the Year” awards consecutively (2023–2024) and lists at least 5 U.S. lab locations, reflecting expanded compliance and R&D work and recognition by thousands of industry voters.
• ProVerde Laboratories accreditation update: ProVerde (one of the early ISO/IEC 17025 cannabis labs) announced/maintained ISO accreditation and expanded its accredited testing scope in recent years, reinforcing demand for accredited thirdparty certificates of analysis (COAs) across regulated markets. 
• Digipath Labs asset sale and consolidation activity: Digipath announced the sale of its testingasset subsidiary in May 2023, illustrating consolidation trends where regional lab assets are being acquired or restructured to improve scale and operational efficiency. 
• Steep Hill facility expansion and M&A activity: Steep Hill expanded capabilities through acquisitions and facility growth (including regional lab acquisitions in U.S. states such as Colorado and Oregon), demonstrating active M&A among legacy testing brands to secure regional share and specialized services. 

Report Coverage of Cannabis Testing Services Market

This report’s coverage spans market sizing and segmentation by test type (potency, pesticide screening, microbial, heavy metals, residual solvents, terpene profiling, mycotoxins), by application & technology (LC/HPLC/UHPLC, GC/GCMS, ICPMS/AAS, qPCR, ELISA, portable spectrometers), and by enduse (cultivators, extractors, manufacturers, distributors, research institutions). The scope includes regional breakdowns across at least 5 macro regions .

Coverage also addresses regulatory testing requirements (number of mandated analytes per panel in key jurisdictions—often 50–60 pesticide lists), logistics and chainofcustody practices, LIMS adoption, proficiency testing participation rates, and commercial models (feepertest, subscription LIMS+reporting, expedited turnaround services).

Cannabis Testing Services Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2270.54 Million in 2026
Market Size Value By	USD 4316.86 Million by 2035
Growth Rate	CAGR of 7.4% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Liquid Chromatography Gas Chromatography Others By Application : Cannabis Drug Manufacturers Cannabis Cultivators/Growers Research Institutes Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample